William Roland Mann - Net Worth and Insider Trading
William Roland Mann Net Worth
The estimated net worth of William Roland Mann is at least $212 dollars as of 2025-01-07. William Roland Mann is the COO of NeuBase Therapeutics Inc and owns about 560 shares of NeuBase Therapeutics Inc (NBSE) stock worth over $212. Details can be seen in William Roland Mann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William Roland Mann has not made any transactions after 2022-03-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William Roland Mann
William Roland Mann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William Roland Mann owns 1 companies in total, including NeuBase Therapeutics Inc (NBSE) .
Click here to see the complete history of William Roland Mann’s form 4 insider trades.
Insider Ownership Summary of William Roland Mann
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBSE | NeuBase Therapeutics Inc | 2022-03-30 | COO |
William Roland Mann Latest Holdings Summary
William Roland Mann currently owns a total of 1 stock. William Roland Mann owns 560 shares of NeuBase Therapeutics Inc (NBSE) as of March 30, 2022, with a value of $212.
Latest Holdings of William Roland Mann
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBSE | NeuBase Therapeutics Inc | 2022-03-30 | 560 | 0.38 | 212 |
Holding Weightings of William Roland Mann
William Roland Mann Form 4 Trading Tracker
According to the SEC Form 4 filings, William Roland Mann has made a total of 2 transactions in NeuBase Therapeutics Inc (NBSE) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in NeuBase Therapeutics Inc is the acquisition of 310 shares on March 30, 2022, which cost William Roland Mann around $11,904.
Insider Trading History of William Roland Mann
- 1
William Roland Mann Trading Performance
GuruFocus tracks the stock performance after each of William Roland Mann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William Roland Mann is -40.05%. GuruFocus also compares William Roland Mann's trading performance to market benchmark return within the same time period. The performance of stocks bought by William Roland Mann within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William Roland Mann's insider trading performs compared to the benchmark.
Performance of William Roland Mann
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -24.92 | | | | | |
| Relative Return to S&P 500(%) | -19.91 | | | | | |
William Roland Mann Ownership Network
William Roland Mann Owned Company Details
What does NeuBase Therapeutics Inc do?
Who are the key executives at NeuBase Therapeutics Inc?
William Roland Mann is the COO of NeuBase Therapeutics Inc. Other key executives at NeuBase Therapeutics Inc include 10 percent owner Symetryx Corp , 10 percent owner Barry Shiff , and 10 percent owner Aleta Shiff .
NeuBase Therapeutics Inc (NBSE) Insider Trades Summary
Over the past 18 months, William Roland Mann made no insider transaction in NeuBase Therapeutics Inc (NBSE). Other recent insider transactions involving NeuBase Therapeutics Inc (NBSE) include a net sale of 428,444 shares made by Symetryx Corp ,
In summary, during the past 3 months, insiders sold 0 shares of NeuBase Therapeutics Inc (NBSE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 489,520 shares of NeuBase Therapeutics Inc (NBSE) were sold and 61,076 shares were bought by its insiders, resulting in a net sale of 428,444 shares.
NeuBase Therapeutics Inc (NBSE)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeuBase Therapeutics Inc Insider Transactions
William Roland Mann Mailing Address
Above is the net worth, insider trading, and ownership report for William Roland Mann. You might contact William Roland Mann via mailing address: 700 Technology Drive, Pittsburgh Pa 15219.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
